FDAnews Device Daily Bulletin

GROWING EVIDENCE SUPPORTS WHAT PATIENTS ALREADY KNOW: CRYSTALENS ACTS LIKE THE EYE'S NATURAL LENS TO DELIVER PREMIUM VISION AT ALL DISTANCES

March 17, 2006
A A

Crystalens, the first and only U.S. Food and Drug Administration-approved accommodating intraocular lens (IOL), today underscored its command of the premium lens channel with data to be presented at the American Society of Cataract and Refractive Surgery annual meeting in San Francisco. Recent clinical data from accommodative arching studies show that the crystalens closely mimics the innate focusing action of the natural crystalline lens -- something no other IOL can claim. This action explains why the majority of crystalens patients are able to achieve a continuous range of vision -- near, distance and intermediate.

Yahoo News (http://biz.yahoo.com/prnews/060316/sfth010.html?.v=39)